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Unique immunologic adaptations exist to successfully establish and maintain pregnancy and to avoid an
immune attack against the semi allogenic fetus. These adaptations occur both locally at the maternofetal
interface and in the peripheral circulation and affect the innate as well as the adaptive immune system.
Pregnancy is characterized by a general inﬂammatory state with activation of monocytes and gran-
ulocytes, but also with suppressive lymphocytes (regulatory T cells), and skewing towards T helper 2
immunity. The pregnancy complication preeclampsia is associated with an exaggerated inﬂammatory
state and predominance of T helper 1 and 17 immunity. The syncytiotrophoblast has been found to
secrete extracellular vesicles as communication factors into the maternal circulation. Syncytiotrophoblast
extracellular vesicles from normal pregnancy have been shown to interact with monocytes, granulocytes,
T cells and natural killer cells and inﬂuence the function of these cells. In doing so, they may support the
inﬂammatory state of normal pregnancy as well as the suppressive lymphocyte phenotype. During
preeclampsia, syncytiotrophoblast extracellular vesicles are not only increased in numbers but also
showed an altered molecular load. Based on data from in vitro studies, it can be suggested that syncy-
tiotrophoblast extracellular vesicles from preeclamptic pregnancies may support the exaggerated in-
ﬂammatory state during preeclampsia. In this review, we discuss the immunological functions of
syncytiotrophoblast extracellular vesicles and their involvement in adapting the maternal peripheral
immunological adaptations to pregnancy.
© 2017 IFPA and Elsevier Ltd. This is an open access article under the CC BY license (http://
creativecommons.org/licenses/by/4.0/).1. Introduction
Unique immunological adaptations exist to successfully
establish and maintain pregnancy. These adaptations prevent an
immune attack on the semi-allogenic fetus, while at the same
time preserving the protection of the maternal body from
external inﬂuences [1]. Therefore, local (at the maternofetal
interface) and peripheral adaptations of the immune responsecell; sFlt-1, soluble fms-like
ellular vesicles; EV, extracel-
sicle; NK, natural killer cell;
anoparticle tracking analysis;
or a; IL, interleukin.
ent of Obstetrics, University
ner).
pen access article under the CC BYcan be found in pregnant women. Changes in the peripheral
immune response are mainly characterized by activation of the
innate immune system and a shift from T helper (Th) 1 and Th17
to a Th2 immune response, with increased numbers of regulatory
T (Treg) cells in the adaptive immune response [2e8]. Adapta-
tions in the peripheral immune response may be due to circu-
lation of immune cells through the placenta and secretion of
factors by the placenta into the maternal circulation, such as
cytokines, placental growth factor, and soluble fms-like tyrosine
kinase 1 (sFlt-1) [9,10].
Preeclampsia (PE) is a complication of the second half of preg-
nancy, mainly characterized by the presence of de novo hyperten-
sion and proteinuria [11]. It affects 2e8% percent of all pregnancies
worldwide and accounts for the death of approximately 76,000
women and 500,000 fetuses per year [12e14]. The only known cure
for PE is the termination of pregnancy which additionally increaseslicense (http://creativecommons.org/licenses/by/4.0/).
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placental dysfunction [17,18], resulting in the production of pro-
inﬂammatory factors by the diseased placenta into the maternal
circulation [19e22]. Such factors may further activate the already
activated innate immune response and affect the adaptive immune
response during pregnancy.
One group of factors produced by the placenta in normal
pregnancy and PE are syncytiotrophoblast extracellular vesicles
(STB EV). Extracellular vesicles (EV) are small membrane-coated
particles [23,24]. Most prokaryotic and eukaryotic cells release EV
into their environment, which indicates that this evolutionary
conserved process is of great importance for a cell. In the human
body, diverse cells, like platelets, monocytes, endothelial cells, tu-
mor cells but also the syncytiotrophoblast (STB), secrete EV during
health and disease and EV are present in all body ﬂuids [23,25e28].
EV are thought to have important signaling functions in many
processes, for instance in immune responses. The secretion of STB
EV is therefore believed to have an essential signaling role during
pregnancy, for instance in the immune adaptions during pregnancy
[23].
In this review, we aim to discuss the possible role of the STB EV
in the immune adaptation of the peripheral immune response to
pregnancy.2. Classiﬁcation and formation of extracellular vesicles
According to their size, mode of formation, function, and cellular
origin, EV can be subdivided into several classes, like macro-
vesicles/apoptotic bodies, microvesicles (MV), exosomes, dex-
trasomes or prostasomes (as reviewed by Ref. [29]), but the
deﬁnitions vary between researchers [30]. Most commonly, EV are
subdivided into macrovesicles/apoptotic bodies, MV and exosomes
[31]. Macrovesicles/apoptotic bodies are relatively large vesicles of
1e5 mm in size, which are formed by blebbing from the plasma
membrane or cellular fragmentation of apoptotic cells. In the
placenta, the fetal villous STB sheds macrovesicles into the
maternal circulation [32]. The STB has an unique nature as being a
very large multinucleated syncytium [33]. As such, the STB func-
tions as the feto-maternal interface which regulates the exchange
of nutrients and waste products between the fetal and maternal
organisms. In contrast to regular macrovesicles, the placenta also
sheds syncytial nuclear aggregates into the maternal circulation,
which carry fetal nucleic acids [34,35]. However, placental macro-
vesicles including the aggregates are cleared from the maternal
blood relatively fast in the maternal lungs [36]. Therefore, they will
not be further object of this review. MV are 100e1000 nm in size
and are formed by cells which are activated, e.g. by renewal or
damage [26,37]. MV are budding directly from the apical side of the
plasma membrane (Fig. 1) [26]. During this process, a translocation
of phosphatidylserines from the intracellular side of the plasma
membrane to the extracellular leaﬂet of the MV membrane may
occur [26,37,38]. Phosphatidylserines are therefore often used as a
speciﬁc MV marker, although MV populations have been described
which do not expose phosphatidylserines on their surface (Table 1)
[7].
Exosomes are small particles of 30e100 nm in size, which are
formed intracellularly, inside early endosomes which are turning
into intracellular multivesicular bodies [39]. The exosomes are
released by fusion of the membrane of these intracellular multi-
vesicular bodies with the plasma membrane (Fig. 1) [29,39].
Additionally, it has been described that exosome-like nanovesicles
are released by budding from the cell membrane (Fig. 1) [39]. It is
not clear yet, how comparable these nanoparticles are to exosomesor if they even can be differentiated from each other [29,39]. In
contrast to MV, exosomes are not expected to expose phosphati-
dylserines on their surface. However, due to the isolation procedure
and freeze-thaw-cycles, also exosome populations have been
described to expose phosphatidylserines under certain circum-
stances [26]. Diverse molecules, such as cluster of differentiation
(CD) 9, CD63, Alix, ﬂotillin-1, and Tsg10 are enriched on exosomes
and can therefore help to identify exosome-enriched fractions
(Table 1) [40,41].
In general, EV are loaded with a plethora of molecules, such as
proteins, (mi)RNA or DNA, which are a reﬂection of the current
state of their originating cell as well as their communication
mission [31,39]. This enables them to inﬂuence speciﬁc target cells,
such as immune cells, like T cells, natural killer (NK) cells, B cells,
monocytes/macrophages or dendritic cells [42,43]. Different EV
subtypes from the same source may share a substantial part of their
molecular cargo, however part of their molecular load is speciﬁc to
the EV subset reﬂecting their mode of formation and their function
[39,44,45].3. Immune function of extracellular vesicles
The functions of EV have been investigated in depth and have
been shown to be manifold (for a review see Ref. [39]). It has been
suggested that cells secret EV to induce angiogenesis, cell survival,
coagulation, waste management, cell communication and immune
adaptation [23,29,39,46]. Since the molecular load of MV and
exosomes differs [29,39,45], it is expected that MV and exosomes
have individual functions, differing from each other.
Many studies have focused on the role of EV in immune re-
sponses. Not only do various immune cells produce EV which affect
immune responses, also the immune response is inﬂuenced by EV
fromnon-immune cells. Both immune cell EV and non-immune cell
EV can induce immune stimulation, but also suppression, they can
stimulate or inhibit inﬂammation, and they can affect autoimmune
diseases and infections [39]. Immune stimulation by EV from im-
mune cells can for instance be induced by EV from antigen pre-
senting cells or B cells, which can directly stimulate T cells [47e49].
Immune stimulation does also take place by EV from endothelial
cells which activate monocytes [50]. Moreover, EV from other cells
may be able to induce immune activation, since it has been shown
that autoantigens are present in the molecular load of thymocyte-
or synovial ﬂuid-derivedMV and exosomes. Such particles could be
involved in the pathogenesis of autoimmunity diseases such as
rheumatic disease [51e53]. Next to immune activation, EV from
immune cells can also induce immune suppression For instance,
plasma exosomes, which are major histocompatibility complex II
positive and CD11b positive (so most likely produced bymonocytes
or macrophages) are able to suppress immune responses in an
antigen speciﬁc manner and dependent on the expression of Fas
Ligand [54]. Moreover, neutrophilic EV impair the
lipopolysaccharide-induced maturation of monocyte-derived den-
dritic cells and reduce their endocytic capacity ﬁnally resulting in
an impaired inﬂammatory process due to failure during T cell
activation [55]. Similarly, EV derived from non-immune cells may
induce immune suppression. This is for instance well known for EV
from tumor cells [56,57]. Exosomes isolated from ascites of ovarian
cancer as well as from blood of head and neck cancer patients
induced differentiation of highly suppressive regulatory T cells, as
well as apoptosis of CD8þ Jurkat cells [28,58]. This indicates that
these EV suppress the anti-tumor immune response For advanced
melanoma patients, it has been shown that MV isolated from
plasma of these patients induce immunosuppressive myeloid cells
Fig. 1. Formation of microvesicles and exosomes.
Microvesicles and exosomes are formed in separate ways from their originating cell. While microvesicles bud from the plasma membrane, exosomes are built in endosomes during
the formation of multivesicular bodies and released by the fusion of the membrane of the multivesicular bodies with the cell membrane. Exosome-like nanovesicles may bud
directly from the plasma membrane. This different mode of formation does not only result in different vesicles sizes, with microvesicles being 100e1000 nm in size and exosomes
being 30e100 nm in size. It also leads to a speciﬁc molecular load of exosomes and microvesicles while certain molecules may also be mutual. Molecules like CD9, CD63, Alix, and
ﬂotillin-1 are enriched on exosomes and can help to identify these fractions. In contrast, CD40, integrins and selectins are enriched on microvesicles and phosphatidylserines are
exposed on the microvesicle surface, thus being useful to identify microvesicles. Origin-speciﬁc marker may be mutual between exosomes and microvesicles. For example, the
placenta expresses cytokeratin and placental alkaline phosphatase and passes them on the STB EV. Correspondently, also the vesicle contents mirror the differences and mutuality
of microvesicles and exosomes. While exosomes typically carry Trg10 in the molecular cargo, a content marker for microvesicles remains still unknown. STB microvesicles and
exosomes however also feature proteins and nucleic acids of their placental origin, such as cytokeratin, placental alkaline phosphatase or the microRNA cluster C19MC.
Table 1
Overview of the types of extracellular vesicles which have been described to be relevant to pregnancy and the development of pregnancy complications.

















CD9, CD63, Alix, ﬂotillin-1, and Tsg10,
placental alkaline phosphatase
intracellularly, early endosomes turn into intracellular multivesicular bodies
which fuse with the plasma membrane and release exosomes
[29,39e41]
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[59].4. Extracellular vesicles in pregnancy and preeclampsia
In general, EV of diverse origin can be found in the circulation
during pregnancy. MV have been described to originate mostly
from platelets, erythrocytes, Th cells, monocytes, B cells and
endothelial cells, but also STB EV were detected in the plasma of
pregnant women [60,61]. Plasma concentrations of total MV were
reduced at 12 weeks of gestation [60], which may reﬂect the
disproportional increase of plasma volume compared to blood cell
volume during pregnancy [62]. However, total MV concentrations
recovered quickly again and subpopulations of MV secreted by
monocytes, erythrocytes and STB increased [60].
Unique to pregnancy is the presence of STB EV in the circulation
of pregnant women [60,63]. As indicated before, we will only focusonMV and exosomes in this review. Table 2 gives an overview of all
studies which have been performed on STB EV in pregnancy and PE
until now. In vitro, it has been shown that the STB releases MV and
exosomes [63,64]. STB EV have been found in the circulation of
pregnant women at concentrations increasing with gestational age
[22]. STBMV have been found in the circulation of pregnant women
from the twelfth week of gestation [22,60,63,65]. STB exosomes
have been found to be increased in thematernal blood already from
early pregnancy, from the sixth week of gestation, onwards [66,67].
A very comprehensive study of Tong et al. compared the mo-
lecular load of ﬁrst trimester placental macrovesicles, MV and
exosomes [45]. They identiﬁed over 1100 mutual proteins in all
three vesicle types; however, up to 223 proteins were speciﬁc to the
respective vesicle type. Most of these proteins were afﬁliated to
physiological cellular processes, transport processes, response
mechanisms or effector processes. These results indicate that
although a large part of the molecular load is shared between
Table 2
Overview of the most important studies concerning syncytiotrophoblast (placental) extracellular vesicles, differences in these vesicle subtypes and their effect on normal and
preeclamptic pregnancy.




Preparation of human placental villous surface membrane Content on STB macrovesilces ex vivo [99]
Pre-eclampsia is associated with an increase in trophoblast glycogen content and
glycogen synthase activity, similar to that found in hydatidiform moles
Content of STB microvesicles in normal and preeclamptic
pregnacies
ex vivo [100]
Shedding of syncytiotrophoblast microvilli into the maternal circulation in pre-
eclamptic pregnancies
Plasma concentration of STB extracellular vesicles in normal
and preeclamptic pregnacies
ex vivo [68]
Trophoblast deportation in human pregnancy–its relevance for pre-eclampsia Origin of STB macrovesicles in normal and preeclamptic
pregnacies
ex vivo [35]
Phagocytosis of Necrotic but Not Apoptotic Trophoblasts Induces Endothelial Cell
Activation
Effects of STB macrovesicles on endothelial cells in vitro [32]
Cytoplasmic microvesicular form of Fas ligand in human early placenta: switching
the tissue immune privilege hypothesis from cellular to vesicular level.
Content of STB extracellular vesicles in normal pregnancy ex vivo [101]
Syncytiotrophoblast micro-particles do not induce apoptosis in peripheral T
lymphocytes but differ in their activity depending on the mode of preparation
Effects of STB extracellular vesicles on immune cells ex vivo [92]
Phosphatidylserine/phosphatidylcholine microvesicles can induce preeclampsia-
like changes in pregnant mice
Effects of STB extracellular vesicles on preeclampsia in vivo
(mice)
[102]
The effects of apoptotic deported human placental trophoblast on macrophages:
Possible consequences for pregnancy
Effects of STB macrovesciles on immune cells ex vivo/
in vitro
[103]
Excess syncytiotrophoblast microparticle shedding is a feature of early-onset pre-
eclampsia but not normotensive intrauterine growth restriction
Plasma concentration of STB extracellular vesicles in normal
and preeclamptic pregnacies and intrauterine growth
retardation
ex vivo [65]
Speciﬁc isolation of placenta-derived exosomes from the circulation of pregnant
women and their immunoregulatory consequences.
Effects of STB exosomes on immune cells ex vivo [104]
Systemic inﬂammatory priming in normal pregnancy and preeclampsia: the role of
circulating syncytiotrophoblast microparticles
Effects of STB extracellular vesicles on immune cells in
normal and preeclamptic pregnacies
ex vivo [22]
Changes in microparticle numbers and cellular origin during pregnancy and
preeclampsia
Plasma concentration of STB extracellular vesicles from
divers origin in normal and preeclamptic pregnacies
ex vivo [60]
T lymphocytes are targets for platelet- and trophoblast-derived microvesicles
during pregnancy
Effects of extracellular vesicles from divers origin on immune
cells in normal pregnacies
ex vivo [90]
Phenotype and mRNA expression of syncytiotrophoblast microparticles isolated
from human placenta.
Content of STB microvesicles in normal pregnancy ex vivo [105]
The effect of labour and placental separation on the shedding of
syncytiotrophoblast microparticles cell-free DNA and mRNA in normal
pregnancy and pre-eclampsia.
Release of STB extracellular vesicles in normal and
preeclamptic pregnacies
ex vivo [106]
Human placenta expresses and secretes NKG2D ligands via exosomes that down-
modulate the cognate receptor expression: evidence for immunosuppressive
function
Content of STB exosomes in normal pregnancy ex vivo [96]
Human villous trophoblasts express and secrete placenta-speciﬁc microRNAs into
maternal circulation via exosomes
Content of STB exosomes in normal pregnancy ex vivo/
in vitro
[107]
Therapeutic effects of anticoagulant agents on preeclampsia in a murine model
induced by phosphatidylserine/phosphatidylcholine microvesicles





Feto-maternal interactions in pregnancies: placental microparticles activate
peripheral blood monocytes.
Effects of STB microvesicles on immune cells ex vivo [88]
Morphologic and proteomic characterization of exosomes released by cultured
extravillous trophoblast cells.
Content and morphology of STB exosomes in normal
pregnancy
in vitro [109]
Trophoblast-derived exosomes mediate monocyte recruitment and differentiation. Effects of STB exosomes on immune cells in vitro [110]
Human trophoblast-derived exosomal ﬁbronectin induces pro-inﬂammatory IL-1b
production by macrophages.
Content of STB exosomes in normal pregnancy in vitro [111]
Sizing and phenotyping of cellular vesicles using Nanoparticle Tracking Analysis. Size characterization of STB microvesicles and exosomes in
normal pregnancy
ex vivo [112]
Syncytiotrophoblast microvesicles released from pre-eclampsia placentae exhibit
increased tissue factor activity
Content of STB extracellular vesicles in normal and
preeclamptic pregnancy
ex vivo [74]
Protein composition of microparticles shed from human placenta during placental
perfusion: Potential role in angiogenesis and ﬁbrinolysis in preeclampsia.
Content of STB extracellular vesicles in normal pregnancy ex vivo [113]
The immunomodulatory role of syncytiotrophoblast microvesicles Effects of STB microvesicles on immune cells ex vivo [46]
Trophoblast debris modulates the expression of immune proteins in macrophages:
a key to maternal tolerance of the fetal allograft?
Effects of STB macrovesicles on immune cells ex vivo [114]
Syncytiotrophoblast-derived microparticle shedding in early-onset and late-onset
severe pre-eclampsia
Plasma concentration of STB microvesicles in normal and
preeclamptic pregnacies and their effect on endothelial cells
ex vivo [69]
The expression proﬁle of C19MC microRNAs in primary human trophoblast cells
and exosomes
Content of STB exosomes in normal pregnancy ex vivo [115]
Immune cell activation by trophoblast-derived microvesicles is mediated by
syncytin 1
Effects of STB microvesicles on immune cells ex vivo/
in vitro
[116]
Heightened pro-inﬂammatory effect of preeclamptic placental microvesicles on
peripheral blood immune cells in humans
Effects of STB microvesicles on immune cells ex vivo [72]
Immunomodulatory molecules are released from the ﬁrst trimester and term
placenta via exosomes
Content of STB microvesicles and exosomes in normal
pregnancy
ex vivo [117]
Multi-dimensional protein identiﬁcation technology analysis of
syncytiotrophoblast vesicles released from perfused preeclampsia placentas
Content of STB extracellular vesicles in normal and
preeclamptic pregnancy
ex vivo [73]
The endogenous retroviral envelope protein syncytin-1 inhibits LPS/PHA-
stimulated cytokine responses in human blood and is sorted into placental
exosomes
Content of STB exosomes in normal pregnancy and their
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Lipidomic analysis of human placental syncytiotrophoblast microvesicles in
adverse pregnancy outcomes
Content of STB extracellular vesicles in normal and
preeclamptic pregnancy
ex vivo [119]
Human placental trophoblasts confer viral resistance to recipient cells Content and anti-viral function of STB exosomes in normal
pregnancy
ex vivo [120]
Multicolor Flow Cytometry and Nanoparticle Tracking Analysis of Extracellular
Vesicles in the Plasma of Normal Pregnant and Pre-eclamptic Women
Plasma concentration of extracellular vesicles from divers
origin in normal and preeclamptic pregnacies
ex vivo [70]
Hypoxia-induced changes in the bioactivity of cytotrophoblast-derived exosomes Content and bioactivity of STB exosomes in normal and
preeclamptic pregnancy
ex vivo [121]
Microvesicles of women with gestational hypertension and preeclampsia affect
human trophoblast fate and endothelial function
Effects of STB microvesicles on trophoblasts and endothelial
cells
ex vivo [122]
Exosomes secreted by human placenta carry functional Fas ligand and TRAIL
molecules and convey apoptosis in activated immune cells suggesting exosome-
mediated immune privilege of the fetus
Content of STB exosomes in normal pregnancy and their
effect on immune cells
ex vivo [94]
Characterization of syncytiotrophoblast vesicles in normal pregnancy and pre-
eclampsia: expression of Flt-1 and endoglin
Content of STB extracellular vesicles in normal and
preeclamptic pregnancy
ex vivo [71]
Proteomic analysis of human placental syncytiotrophoblast microvesicles in
preeclampsia
Content of STB extracellular vesicles in normal and
preeclamptic pregnancy
ex vivo [123]
Lipidomic analysis of human placental Syncytiotrophoblast microvesicles in
adverse pregnancy outcomes
Content of STB extracellular vesicles in normal and
preeclamptic pregnancy
ex vivo [124]
Placental expression of aminopeptidase-Q (laeverin) and its role in the
pathophysiology of preeclampsia





A gestational proﬁle of placental exosomes in maternal plasma and their effects on
endothelial cell migration
Content of STB exosomes in normal pregnancy and their
effect on endothelial cells
ex vivo [126]
Placenta-derived exosomes continuously increase in maternal circulation over the
ﬁrst trimester of pregnancy
Plasma concentration of STB exosomes in normal pregnacies ex vivo [66]
Trophoblast debris extruded from preeclamptic placentae activates endothelial
cells: a mechanism by which the placenta communicates with the maternal
endothelium
Effects of STB extracellular vesicles on endothelial cells ex vivo [127]
Plasma biomarker discovery in preeclampsia using a novel differential isolation
technology for circulating extracellular vesicles
Content of extracellular vesicles from divers origin in normal
pregnacies
ex vivo [128]
Syncytin proteins incorporated in placenta exosomes are important for cell uptake
and show variation in abundance in serum exosomes from patients with
preeclampsia





Isolation of syncytiotrophoblast microvesicles and exosomes and their
characterization by multicolor ﬂow cytometry and ﬂuorescence Nanoparticle
Tracking Analysis
Detection/characterization of STB microvesicles and
exosomes in normal pregnancy
ex vivo [64]
A New Enzyme-linked Sorbent Assay (ELSA) to Quantify Syncytiotrophoblast
Extracellular Vesicles in Biological Fluids
Quantiﬁcation of STB extracellular vesicles in liquid samples ex vivo/
in vitro
[63]
Differential Proteomic Analysis of Syncytiotrophoblast Extracellular Vesicles from
Early-Onset Severe Preeclampsia using 8-Plex iTRAQ Labeling Coupled with 2D
Nano LC-MS/MS
Content of STB extracellular vesicles in normal and
preeclamptic pregnancy
ex vivo [130]
Antiphospholipid antibodies bind syncytiotrophoblast mitochondria and alter the
proteome of extruded syncytial nuclear aggregates
Content of STB macrovesicles in normal and preeclamptic
pregnancy
ex vivo [131]
The Effect of Glucose on the Release and Bioactivity of Exosomes from First
Trimester Trophoblast Cells
Concentration of STB exosomes and their effects on immune
cells under inﬂuence of glucose
ex vivo [132]
Studies of the dynamics of nuclear clustering in human syncytiotrophoblast Release of STB macrovesicles in normal pregnacies ex vivo/
in vitro
[98]
Isolation of human trophoblastic extracellular vesicles and characterization of their
cargo and antiviral activity
Detection/characterization of STB microvesicles and
exosomes in normal pregnancy
ex vivo [133]
Placental exosomes and pre-eclampsia: Maternal circulating levels of normal
pregnancies and early and late onset pre-eclamptic pregnancies
Plasma concentration of STB exosomes in normal and
preeclamptic pregnacies
ex vivo [67]
Microvesicles of pregnant women receiving lowmolecular weight heparin improve
trophoblast function





Flow speed alters the apparent size and concentration of particles measured using
NanoSight nanoparticle tracking analysis
Detection of STB extracellular vesicles ex vivo/
in vitro
[135]
Proteomic characterization of macro- micro- and nano-extracellular vesicles
derived from the same ﬁrst trimester placenta: relevance for feto-maternal
communication
Contents of STB extracellular vesicles in normal pregnancies ex vivo [45]
Trophoblast Glycoprotein (TPGB/5T4) in Human Placenta: Expression, Regulation,
and Presence in Extracellular Microvesicles and Exosomes
Content of STB microvesicles and exosomes in normal
pregnancy
ex vivo [136]
Inﬂuence of maternal BMI on the exosomal proﬁle during gestation and their role
on maternal systemic inﬂammation
Plasma concentration of STB exosomes in normal and obese
pregnacies and their inﬂuence on immune cells
ex vivo [137]
Detection of Fetal Sex Aneuploidy and a Microdeletion from Single Placental
Syncytial Nuclear Aggregates
Content of STB macrovesicles ex vivo [34]
Placental exosomes as early biomarker of preeclampsia - Potential role of exosomal
microRNAs across gestation
Plasma concentration of STB exosomes in normal and
preeclamptic pregnacies
ex vivo [138]
Oxygen tension regulates the miRNA proﬁle and bioactivity of exosomes released
from extravillous trophoblast cells - Liquid biopsies for monitoring
complications of pregnancy
Content of extravillous trophoblast exosomes in normal




Treating normal early gestation placentae with preeclamptic sera produces
extracellular micro and nano vesicles that activate endothelial cells
Content of STB microvesicles and exosomes in normal and
preeclmaptic pregnancy and their effect on endothelial cells
ex vivo [140]
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each vesicle type based on the partially speciﬁc molecular load.
In PE, the secretion of STB EV has been shown to be signiﬁcantly
increased compared to normal pregnancy [65,67e69]. Other
studies, however, have shown a decreased number of STB EV in
preeclamptic patients [60,70]. The inconsistency between studies
may be due to the methods applied. The studies that found
increased numbers of STB EV in PE used an enzyme linked immu-
nosorbent assay to measure STB EV. This method detects vesicles
from all sizes. The studies that did not ﬁnd increased STB EV in PE
used ﬂow cytometry. Since ﬂow cytometry detects only larger
particles, i.e. over 300 nm, this may suggest that differences in STB
EV numbers between pregnant and preeclamptic womenwould be
found in the smaller EV, i.e. below 300 nm. Indeed, a study by
Tannetta et al. using nanoparticle tracking analysis (NTA), and a
study by Holder et al. using electron microscopy, showed that dif-
ferences in particle size between perfusates from placentae of
healthy pregnant women and preeclamptic women were mainly
found in the particles below 300 nm [71,72].
STB EV have not only been shown to be increased in PE as
compared with normal pregnancy, but they also show a partially
different molecular load than the STB EV of normal pregnancy [73].
Preeclamptic STB EV may also expose different molecules, since
they expose an increased amount of tissue factor [74], and endoglin
and fms-like tyrosine kinase 1 (Flt-1) [71]. This may indicate an
altered functionality of STB EV during PE. However, it remains
unclear how the molecular load of the vesicles is coordinated and
which factors inﬂuence the differences in the molecular load of
normal and preeclamptic STB EV.
5. Peripheral immune adaptions in pregnancy and
preeclampsia
Pregnancy-related adaptations of the maternal immune system
have been shown in both the adaptive and the innate immune
response, both locally at the implantation site as well as in the
peripheral circulation [75e78]. Potential local (uterine) effects of
the STB EV are unknown to date. In future studies, it is worth
considering whether STB EV can directly interact with uterine NK
cells and monocytes/macrophages in the decidua and may be
involved in uterine NK cell and macrophage function in healthy
pregnancy as well as in alterations of these cell types between
healthy and preeclamptic pregnancy, e.g. rather
immunomodulatory/tolerance-inducing M2 macrophages in
normal pregnancy vs. rather inﬂammatoryM1macrophages during
PE [79,80]. Since the STB EV will mainly affect the peripheral im-
mune response in pregnant women, we will discuss changes in the
peripheral immune response in pregnancy and PE.
The peripheral immune response during healthy pregnancy is
characterized by a generalized pro-inﬂammatory state
[75,76,81,82]. Monocytes and granulocytes of pregnant women are
not only increased in numbers but also show an activated pheno-
type and a different cytokine expression as compared with non-
pregnant women [76,81,83]. The monocytes also show character-
istics of maturation by shifting from CD16 classical monocytes to
CD16þ intermediate monocytes [75,84]. Dendritic cell function
seems to be suppressed to avoid an activation of the T cell response
against the fetus [85]. Changes also take place in the adaptive im-
mune response: there is an increase of Treg cells and a shift from
Th1 and Th17 immunity towards type-2 immunity in Tcells, NK and
natural killer T (NKT) cells [2e8].
Compared to normal pregnancy, PE is associated with an exag-
geration of the systemic inﬂammatory state characterized by
endothelial and leukocyte activation [68]. It has been shown, that
numbers and the activational state of monocytes and granulocytesare increased compared to normal pregnancy and that a stronger
shift towards CD16þ intermediate monocytes occurs [75,76,81].
Additionally, Treg cells are reduced and Th1 and Th17 cells are
predominant during PE, increasing the Th1/Th2 and Th17/Treg ra-
tios [2,75,80,86,87]. Also, NK and NKT cells tend to produce more
type-1 cytokines during PE compared to normal pregnancy
[2,75,80].
6. Immune function of syncytiotrophoblast extracellular
vesicles in pregnancy and preeclampsia
As indicated above, EV have many immunological functions.
Indeed, evidence is growing for a role of STB EV in the immuno-
logical adaptations to pregnancy. A potential role for STB EV in the
activation of the innate immune system during pregnancy has been
shown by in vitro and in vivo studies indicating that monocytes can
bind and internalize STB EV [22,46,88]. Due to this STB EV binding
and uptake, monocytes start producing various cytokines, such as
tumor necrosis factor a (TNF-a) and interleukin (IL)-1-b [22,46,88].
Also, neutrophils seem to be activated by STB EV in vitro, since it has
been shown that neutrophils incubated with STB EV produce
increased levels of superoxide [89]. Our own data showed that STB
EV from normal placentae not only activate monocytes (by upre-
gulating CD11b expression) in vitro, but also induce maturation of
monocytes by inducing a shift from classical to intermediate
monocytes (unpublished).
The STB EV may also affect the adaptive immune response
during pregnancy, since they have been found to bind to peripheral
T and B cells and to increase signal transducer and activator of
transcription 3 phosphorylation in T cells in vitro [46,90,91].
Furthermore, STB EV increased interferon g production in T lym-
phocytes [22,92]. Additionally, STB EV are able to down-regulate
proliferation of T cells induced by for instance phytohaemag-
glutinin [92,93]. However, the exact effect of STB EVmay depend on
the mode of their preparation [92]. For a better comparability of
different studies with each other and to the in vivo situation, the
preparation methods should be standardized in future studies.
Additionally, the way in which STB EV interact with their target
cells needs to be clariﬁed. For example, the expression of FASL and
TRAIL on STB EV may indicate that STB EV are able to induce
apoptosis in Tcells [94]. Furthermore, STB EVwere found to have an
inhibitory effect on the allogeneic reactivity of T cells in mixed
lymphocyte reactions [95]. Our own results showed that STB EV
isolated from perfused normal placentae may have a regulatory
function: we have shown that STB EV activated Treg cells and
memory T cells in vitro (unpublished). Although it has not been
shown that STB EV can bind to NK cells, it has been shown that STB
EV express ligands for the activating NK cell receptor NKG2D (MIC
A/B). This is indicative for an interaction of STB EV with NK cells
[96]. and indeed, STB EV can induce interferon g production in NK
cells [22], suggesting that STB EV do have an effect on NK cells. Also,
different immune cell types might interact with each other and
activate each other after interacting with STB EV. Future studies
should thus focus on the actual interaction of STB EV with immune
cells and evaluate which reactions can be attributed to direct STB
EV contact and which might be a product of interaction of different
immune cells.
Unfortunately, only few studies have been performed so far on
the immunologic impact of STB EV from preeclamptic placentae.
STB EV from explant cultures of preeclamptic placentae were able
to induce increased secretion of proinﬂammatory cytokines such as
IL1-b, IL-6, IL-17, macrophage inhibitory protein-1-a and -b, or TNF-
a in peripheral blood mononuclear cells compared to STB EV from
normal placenta explants [72]. Additionally, STB EV from pre-
eclamptic placental explants increased the response of peripheral
C. G€ohner et al. / Placenta 60 (2017) S41eS51 S47blood mononuclear cells towards lipopolysaccharide while STB EV
from normal placental explants suppressed the response of pe-
ripheral blood mononuclear cells to lipopolysaccharide [72]. This
may suggest that STB EV from preeclamptic placentae may be
involved in the exaggerated inﬂammatory response in PE. Our own
study, however, showed that the effects of STB EV from pre-
eclamptic women on monocyte activation (as measured by CD11b
expression) were similar to the effects of STB EV from normal
pregnant women. Our recent studies also showed that, in contrast
to STB EV from normal placentae, STB EV derived from pre-
eclamptic placentae failed to activate Treg and memory T cells
(unpublished). In vivo, such a failure to induce a regulatory
lymphocyte phenotype may enable the exaggerated inﬂammatory
state of PE. Additional studies are needed to better align the ex vivo/
in vitro effects seen in former studies and to compare this to the
in vivo situation.
In conclusion, STB EV seem to represent a powerful means ofFig. 2. The role of syncytiotrophoblast extracellular vesicles in the immunologic regulation
To effectively communicate with the maternal body, the placenta secretes extracellular (STB E
the STB EV can interact with immune cells. On the one hand, they may activate monocytes a
other hand, they may inhibit T helper and cytotoxic T cells, while promoting immuno-regu
centration of circulating STB EV is increased and their molecular load is altered. This can su
regulation. However, the molecular load of STB EV in healthy and preeclamptic pregnancy,
remain to be established in future studies.communication between the placenta and the maternal body
(Fig. 2). STB EV are present in the maternal circulation already from
early pregnancy onwards and increase over the course of preg-
nancy. In vitro studies suggest that STB EV from healthy pregnant
women can activate various inﬂammatory cells, such as monocytes
and granulocytes, and therefore may be involved in inducing the
physiologic general inﬂammatory state of pregnancy. Additionally,
STB EV may inhibit T and NK cell functions, but induce activation of
regulatory T cells and memory cells, and therefore may have a
regulatory function. During PE, not only STB EV numbers are
increased but also their molecular load is altered compared to
normal pregnancy. Indeed, STB EV from preeclamptic pregnancies
might support the exaggerated inﬂammatory state during PE.
However, there are only a few studies addressing the immunologic
function of STB EV from preeclamptic placentae. Moreover, func-
tional studies on STB EV (both from healthy pregnancies and from
preeclamptic pregnancies) have only been performed ex vivo/of pregnancy.
V) vesicles from the syncytiotrophoblast into the maternal circulation. Amongst others,
nd granulocytes, thus supporting the systemic inﬂammatory state of pregnancy. On the
lation through activation of regulatory and memory T cells. In preeclampsia, the con-
pport the exaggerated inﬂammatory state during preeclampsia and disturb immuno-
their mode of interaction with target cells and potential therapeutic interaction points
C. G€ohner et al. / Placenta 60 (2017) S41eS51S48in vitro. Therefore, future research should focus on the in vivo
function of the STB EV and on functional studies on STB EV, espe-
cially STB EV from preeclamptic placentae, to unravel their role in
normal and preeclamptic pregnancies. This should include studies
on molecular differences between STB MV and STB exosomes, but
also studies into the interactions of STB EV with their target cells,
e.g. by clathrin-mediated or caveolin-dependent endocytosis,
micropinocytosis, phagocytosis, lipid rafts or cell surface mem-
brane fusion. Ultimately, these studies should improve our under-
standing of STB EV function and open up new avenues to
therapeutically interfere with STB EV signaling.
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